-+ 0.00%
-+ 0.00%
-+ 0.00%

Nano Dimension appoints Oramed CEO Nadav Kidron to board to chair strategy, capital allocation committee

PUBT·08/17/2026 12:02:28
Listen to the news
Nano Dimension appoints Oramed CEO Nadav Kidron to board to chair strategy, capital allocation committee
  • Nano Dimension appointed Oramed Pharmaceuticals CEO Nadav Kidron to its board to chair a new Strategy and Capital Allocation Committee.
  • The committee will review capital allocation options, including potential shareholder returns, monetization of non-core assets, and strategic opportunities.
  • Kidron is CEO and a director of Oramed, a significant shareholder, and serves on the boards of Alpha Tau Medical and Lifeward.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano Dimension Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608170800PRIMZONEFULLFEED9811153) on August 17, 2026, and is solely responsible for the information contained therein.